Early highly active antiretroviral therapy enhances B-cell longevity: a 5 year follow up.

Background:We have previously reported that an early initiation of highly active antiretroviral therapy (HAART) in HIV-1 vertically infected children enhanced the function of memory B-cells gained during childhood routine vaccinations. On the other hand, a significant waning of immunity was observed